Disease / condition

Vulvovaginal Candidiasis, Genital clinical trials

Free access to 2 studies·2+ countries·Updated daily1 recruiting
2
Total trials
2+
Countries
2+
Sponsors
1
Recruiting
By phase
Phase 31
N/A1
By status
Completed1
Recruiting1
Top countries
Mauritius1
Russian Federation1
Top sponsors
Avva Rus, JSC1
Biocodex1
Recent trials
Latest clinical trials for Vulvovaginal Candidiasis, Genital
NCT06411314·Phase 3Completed
Efficacy and Safety of Natamycin and Lactulose Vaginal Suppositories in Treatment of Vulvovaginal Candidiasis
Avva Rus, JSCRussian Federation
NCT05273333Recruiting
Effect of Ultra-gyn® on Vulvovaginal Candidiasis
BiocodexMauritius
About this record

Access comprehensive clinical trial information for Vulvovaginal Candidiasis, Genital through Pure Global AI's free database. This collection includes 2 clinical trials across multiple phases including Phase 3, N/A. Currently, 1 trials are actively recruiting participants.

Research for Vulvovaginal Candidiasis, Genital is being conducted in Mauritius, Russian Federation and more. Leading sponsors include Avva Rus, JSC and Biocodex. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 2 clinical trials studying Vulvovaginal Candidiasis, Genital, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 2+ countries.

Top research sponsors include Avva Rus, JSC, Biocodex, among others.